In our cohort, 4 patients discontinued the CDK4/6i for reasons other than disease progression and remained on ET alone (2 due to patient preference during the COVID pandemic; 1 due to recurrent infection; 1 due to liver toxicity). This evidence concerns the gene CDK4 and infection.